AI assistant
LifeMD, Inc. — Director's Dealing 2019
Mar 4, 2019
33298_dirs_2019-03-04_945497c3-c694-471d-a388-4f2385603f36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-03-01
Reporting Person: Kalkstein Robert L (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-10-01 | Options to purchase Common Stock | $0.28 | J | 150000 | Acquired | 2027-09-30 | Common Stock (150000) | Direct |
| 2019-03-01 | Options to purchase Common Stock | $0.28 | J | 150000 | Acquired | 2027-09-30 | Common Stock (150000) | Direct |
Footnotes
F1: These options were previously reported by Mr. Kalkstein on his Form 3 filed with the Commission on November 13, 2017. Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28.
F2: Pursuant to an amendment to his consulting agreement with Conversion Labs, Inc., the exercise price of these options were reduced from $0.40 to $0.28 and now vest on March 31, 2019. Additionally, the 200,000 to be issued to Mr. Kalkstein pursuant to his consulting agreement were cancelled and Mr. Kalkstein also has forgone $32,500 owed to him by Conversion Labs, Inc.